NCT06377657

Brief Summary

Diabetes is a prevalent metabolic disease that leads to increased blood sugar levels due to insulin shortage or resistance. Type 2 diabetes is often linked to obesity, which can increase insulin resistance. Meteorin-like protein (METRNL) is a new secreted protein that affects insulin sensitivity and has been found to be negatively related to serum glucose levels in people with diabetes. Oxidative stress in diabetics can stimulate the production of inflammatory mediators, increasing the activity of the antioxidant system. Aloe vera, a widely used plant, has been used for treating diabetes, wound healing, tumors, and inflammatory bowel disease. It has anti-inflammatory, antioxidant, neuroprotective, antidepressant, and memory-enhancing effects. Exercise can improve diabetic patients' conditions by increasing the expression of GLUT4 protein and skeletal muscle. High-intensity interval training has been shown to increase the expression of the METORIN gene in human subjects and decrease MDA in type 2 diabetic patients. However, no studies have examined the simultaneous effect of exercise and Aloe vera on diabetes indicators. The present study aims to investigate the response of METRNL and some oxidative and antioxidant plasma indicators to high-intensity interval training and Aloe vera supplementation in type 2 diabetic men. The findings indicate that exercise and consumption of plants with anti-inflammatory and antioxidant properties can be effective in modulating the pathological effects of diabetes and increasing insulin sensitivity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 21, 2023

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 19, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 23, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 22, 2024

Completed
Last Updated

April 22, 2024

Status Verified

April 1, 2024

Enrollment Period

1.4 years

First QC Date

March 23, 2024

Last Update Submit

April 17, 2024

Conditions

Keywords

exercise, blood glucose oxidative stress, diabetes mellitus

Outcome Measures

Primary Outcomes (1)

  • METRNL - Meteorin Like, Glial Cell Differentiation Regulator

    Plasma METRNL content was measured using a special kit (Mybiosource company, USA) with a sensitivity of \<0.64 ng / ml, range of 1.56-100 ng / ml by ELISA method

    Baseline and 12 weeks

Secondary Outcomes (4)

  • Glutathione peroxidase (GPx)

    Baseline and 12 weeks

  • Serum superoxide dismutase (SOD)

    Baseline and and 12 weeks

  • Total antioxidant blood capacity (TAD)

    Baseline and 12 weeks

  • Plasma malondialdehyde (MDA)

    Baseline and 12 weeks

Study Arms (4)

High-Intensity Interval Training

EXPERIMENTAL

Participants in HIIT group underwent 3 sessions per week for 12 weeks. The HIIT protocol (maximum 60 cycles per 20-minute session) includes 8-second fast pedaling (approximately 80% of maximum heart rate (HR max)) followed by slow pedaling (20-30 rpm) for 12 seconds. To facilitate acceleration and limit the stagnation of the bicycle wheel, the selected resistance was very low (almost zero).

Behavioral: Exercise

Aloe Vera supplementation

EXPERIMENTAL

Participants in Aloe Vera group underwent supplementation with Aloe vera capsule containing 100 mg of Aloe vera gel powder in the morning immediately after waking up and one capsule after dinner.

Dietary Supplement: Aloe vera

HIIT + Aloe Vera

EXPERIMENTAL

Participants in HIIT group underwent 3 sessions per week for 12 weeks. The HIIT protocol (maximum 60 cycles per 20-minute session) includes 8-second fast pedaling (approximately 80% of maximum heart rate (HR max)) followed by slow pedaling (20-30 rpm) for 12 seconds. To facilitate acceleration and limit the stagnation of the bicycle wheel, the selected resistance was very low (almost zero). Additionally, patients underwent supplementation with Aloe Vera capsules in the morning and after the dinner.

Behavioral: ExerciseDietary Supplement: Aloe vera

Control group

NO INTERVENTION

The control group continued their daily life activities for 12 weeks

Interventions

ExerciseBEHAVIORAL

The HIIT group underwent intervention with high intensity interval training. The second group was treated only with aloe vera supplementation for 12 weeks. A third group underwent a combination of HIIT and supplementation, while a fourth - CON group kept usual activities during the intervention duratino

HIIT + Aloe VeraHigh-Intensity Interval Training
Aloe veraDIETARY_SUPPLEMENT

Aloe Vera group was treated only with aloe vera supplementation for 12 weeks.

Aloe Vera supplementationHIIT + Aloe Vera

Eligibility Criteria

Age25 Years - 40 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Male participants who have been diagnosed with T2DM at least 3 months prior to the start of the study according to standard criteria
  • Inactive participants according to the International Physical Activity Questionnaire (IPAQ)
  • Participants receiving stable medical therapy for T2DM, excluding those on exogenous insulin therapy
  • Participants who were free from injuries or chronic health conditions that could limit their ability to safely participate in an intense exercise program were included in the study

You may not qualify if:

  • Fasting glucose above 270 mg / dL
  • Exogenous insulin
  • History of diabetic complications (the final stage of proliferative diabetic retinopathy, or subsequent overt nephropathy, diabetic ketoacidosis, or severe diabetic neuropathy)
  • Hereditary glucose and galactose malabsorption

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Sport Physiology, Faculty of Sport and Physical education, Islamic Azad University of Ayatollah Amoli, Amol, Iran

Āmol, Iran

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Motor ActivityDiabetes Mellitus

Interventions

Exercise

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Anja Lazić, Prof.

    Faculty of Sport and Physical Education, University of Niš

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The participants were blinded for the supplementation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Junior Researcher

Study Record Dates

First Submitted

March 23, 2024

First Posted

April 22, 2024

Study Start

January 15, 2022

Primary Completion

June 21, 2023

Study Completion

February 19, 2024

Last Updated

April 22, 2024

Record last verified: 2024-04

Locations